Johnson & Johnson (JNJ) insider trading in the last 6 months
6 insiders sold $70.2M. No buys.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at Johnson & Johnson
Questions about JNJ's insider trades
Are JNJ insiders buying or selling?
6 insiders sold $70.2M across 11 filings in the last 6 months. No open-market buys on record. The newest filing: Timothy Schmid, EVP, WW Chair, MedTech, sold $6.2M on Sep 2, 2026.
Who are JNJ's biggest insider sellers?
By the dollars of their sales in the last 6 months: Joaquin Duato (CEO and Chairman of the Board), 4 sales; Timothy Schmid (EVP, WW Chair, MedTech), 2 sales; Vanessa Broadhurst (EVP, Global Corp Affairs), 1 sale. 6 insiders sold in all.
When did a JNJ insider last buy?
No JNJ insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Timothy Schmid on Sep 2, 2026.
Johnson & Johnson's page has its Quality Score, its chart, and its earnings. More in Healthcare and Pharma.